Zobrazeno 1 - 10
of 355
pro vyhledávání: '"Takahiro YAMASAKI"'
Autor:
Jun Nishikawa, Tomohiro Fujii, Soichiro Fukuda, Shoma Yoneda, Yuta Tamura, Yuki Shimizu, Akie Yanai, Yuki Kobayashi, Koji Harada, Keisuke Kawasaki, Katsuaki Mishima, Kenji Watanabe, Yoichi Mizukami, Hironori Yoshiyama, Yutaka Suehiro, Takahiro Yamasaki, Taro Takami
Publikováno v:
Journal of Microbiology, Immunology and Infection, Vol 57, Iss 4, Pp 533-545 (2024)
Background: Periodontal disease is the leading cause of tooth loss, and an association between periodontal disease and non-oral systemic diseases has been shown. Formation of biofilm by periodontal pathogens such as Fusobacterium nucleatum, Porphyrom
Externí odkaz:
https://doaj.org/article/e5b123f32b8046f6abb3bd0a53afad72
Autor:
Yuki Wasai, Naoyuki Yamada, Nobuaki Ariyoshi, Aiko Haraguchi, Masahiko Funatsu, Masanori Mikuni, Riku Nakamura, Ayano Sakuma, Fumiaki Higashijima, Nanako Iwamoto, Shinichiro Teranishi, Mitsuaki Nishioka, Takahiro Yamasaki, Kazuhiro Kimura
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-7 (2024)
Abstract The potential risks associated with organs from COVID-19-infected donors were unclear. To determine the SARS-CoV-2 infection status of corneas transplanted during the COVID-19 pandemic, we performed a polymerase chain reaction (PCR) using th
Externí odkaz:
https://doaj.org/article/b6d2bb491d67455eb62275ae64d58b67
Autor:
Masakazu Ozaki, Toshihiko Kobayashi, Aki Fujinaga, Mitsuaki Nishioka, Kyoko Shikichi, Satoshi Okano, Yasuhito Sakai, Sayumi Fujii, Nobuaki Matsui, Miwako Takasago, Naoto Okada, Takahiro Yamasaki, Takashi Kitahara
Publikováno v:
Journal of Pharmaceutical Health Care and Sciences, Vol 9, Iss 1, Pp 1-8 (2023)
Abstract Background Pharmaceutical companies do not sell formulations for all diseases; thus, healthcare workers have to treat some diseases by concocting in-hospital preparations. An example is the high-concentration 2% cyclosporine A (CyA) ophthalm
Externí odkaz:
https://doaj.org/article/aa4113ea04394a03abef6823a5f962e2
Autor:
Yuki Kunimune, Yutaka Suehiro, Issei Saeki, Yurika Yamauchi, Norikazu Tanabe, Toshihiko Matsumoto, Shingo Higaki, Ikuei Fujii, Chieko Suzuki, Naoko Okayama, Mitsuaki Nishioka, Kiyoshi Ichihara, Hiroaki Nagano, Isao Sakaida, Taro Takami, Takahiro Yamasaki
Publikováno v:
Liver Cancer (2024)
Background: Patients with hepatitis virus-related hepatocellular carcinoma (viral HCC) are decreasing as hepatitis control improves, but those with non-viral-related HCC (non-viral HCC) are increasing in Japan. No established surveillance system exis
Externí odkaz:
https://doaj.org/article/a0703f6b2ca94c5297d352e3e8d34602
Autor:
Issei Saeki, Takahiro Yamasaki, Yurika Yamauchi, Tomokazu Kawaoka, Shinsuke Uchikawa, Akira Hiramatsu, Hiroshi Aikata, Kazufumi Kobayashi, Takayuki Kondo, Sadahisa Ogasawara, Tetsuhiro Chiba, Reo Kawano, Kazuaki Chayama, Naoya Kato, Taro Takami
Publikováno v:
Cancer Medicine, Vol 12, Iss 9, Pp 10625-10635 (2023)
Abstract Aim Skeletal muscle volume has been reported to be an important factor that determines overall survival (OS) and post‐progression survival (PPS) in patients with hepatocellular carcinoma (HCC). However, the impact of skeletal muscle volume
Externí odkaz:
https://doaj.org/article/264ad3bdf8c3415999ff96b985e4fa87
Autor:
Reiji Fukano, Yuka Iijima-Yamashita, Hideto Iwafuchi, Atsuko Nakazawa, Akiko M. Saito, Tetsuya Takimoto, Masahiro Sekimizu, Yutaka Suehiro, Takahiro Yamasaki, Shunji Hasegawa, Tetsuya Mori, Keizo Horibe
Publikováno v:
Haematologica, Vol 109, Iss 2 (2023)
Externí odkaz:
https://doaj.org/article/72e6b2ed2692446cb32776cf68528038
Autor:
Koichi Fujisawa, Taro Takami, Toshihiko Matsumoto, Naoki Yamamoto, Takahiro Yamasaki, Isao Sakaida
Publikováno v:
Cancer & Metabolism, Vol 10, Iss 1, Pp 1-11 (2022)
Abstract Background Although iron chelation has garnered attention as a novel therapeutic strategy for cancer, higher levels of efficacy need to be achieved. In the present study, we examined the combinatorial effect of deferoxamine (DFO), an iron ch
Externí odkaz:
https://doaj.org/article/617732e7fab8407dbd312e174a5c4347
Autor:
Shogo Amano, Seiji Kaino, Shuhei Shinoda, Hirofumi Harima, Toshihiko Matsumoto, Koichi Fujisawa, Taro Takami, Naoki Yamamoto, Takahiro Yamasaki, Isao Sakaida
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-1 (2023)
This article has been retracted. Please see the Retraction Notice for more detail: https://doi.org/10.1186/s12885-023-11677-6.
Externí odkaz:
https://doaj.org/article/1da1f8b04d04465d9c5d3eafd55e5734
Correction: Invasion inhibition in pancreatic cancer using the oral iron chelating agent deferasirox
Autor:
Shogo Amano, Seiji Kaino, Shuhei Shinoda, Hirofumi Harima, Toshihiko Matsumoto, Koichi Fujisawa, Taro Takami, Naoki Yamamoto, Takahiro Yamasaki, Isao Sakaida
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-2 (2023)
Externí odkaz:
https://doaj.org/article/4c91c6176aba4c23b8f184812284224b
Metabolic Analysis of DFO-Resistant Huh7 Cells and Identification of Targets for Combination Therapy
Publikováno v:
Metabolites, Vol 13, Iss 10, p 1073 (2023)
Hepatocellular carcinoma (HCC) is one of the most refractory cancers with a high rate of recurrence. Iron is an essential trace element, and iron chelation has garnered attention as a novel therapeutic strategy for cancer. Since intracellular metabol
Externí odkaz:
https://doaj.org/article/cc66af569e2f4e6ba71a8508f4220e1e